The discovery of its receptor or enzymes modulated by BAIBA will not only unveil the physiological role of this amino acid, but also provide an opportunity to design novel drugs for the treatment of obesity, diabetes, dyslipidemia, and atherosclerosis. The gene discussed is AGXT2; the disease is metabolic syndrome.